Literature DB >> 16718353

Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma.

Kazuhiko Mishima1, Yukinari Kato, Mika K Kaneko, Youya Nakazawa, Akiko Kunita, Naoya Fujita, Takashi Tsuruo, Ryo Nishikawa, Takanori Hirose, Masao Matsutani.   

Abstract

Podoplanin, a mucin-like transmembrane sialoglycoprotein, promotes platelet aggregation and may be involved in cancer cell migration, invasion, metastasis, and malignant progression. Podoplanin/aggrus is highly expressed in testicular seminoma, suggesting that it may be a sensitive marker for testicular seminomas. Here we investigated the expression of podoplanin in central nervous system (CNS) germ cell tumors (GCTs) by immunohistochemical staining of tumor samples from 62 patients. In 40 of 41 (98%) germinomas (including germinomatous components in mixed GCTs), podoplanin was diffusely expressed on the surface of germinoma cells; lymphocytes, interstitial cells, and syncytiotrophoblastic giant cells were negative for podoplanin. Except for immature teratomas (12/17; 71%), podoplanin expression was absent in non-germinomatous GCTs, including seven teratomas, seven embryonal carcinomas, seven yolk sac tumors, and seven choriocarcinomas. In immature teratomas, focal podoplanin staining was observed in fewer than 10% of immature squamous and columnar epithelial cells. Thus, podoplanin expression may be a sensitive immunohistochemical marker for germinoma in CNS GCTs. As such, it may be useful for diagnosis, for monitoring the efficacy of treatment, and as a potential target for antibody-based therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718353     DOI: 10.1007/s00401-006-0033-4

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Podoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survival.

Authors:  Haruhisa Kitano; Shun-Ichiro Kageyama; Stephen M Hewitt; Ryuji Hayashi; Yoshinori Doki; Yoshitomo Ozaki; Shozo Fujino; Mikiko Takikita; Hajime Kubo; Junya Fukuoka
Journal:  Arch Pathol Lab Med       Date:  2010-10       Impact factor: 5.534

2.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

3.  Genome-wide two-locus epistasis scans in prostate cancer using two European populations.

Authors:  Sha Tao; Junjie Feng; Timothy Webster; Guangfu Jin; Fang-Chi Hsu; Shyh-Huei Chen; Seong-Tae Kim; Zhong Wang; Zheng Zhang; Siqun L Zheng; William B Isaacs; Jianfeng Xu; Jielin Sun
Journal:  Hum Genet       Date:  2012-02-26       Impact factor: 4.132

Review 4.  Podoplanin: a novel regulator of tumor invasion and metastasis.

Authors:  Qi Dang; Jie Liu; Juan Li; Yuping Sun
Journal:  Med Oncol       Date:  2014-08-21       Impact factor: 3.064

5.  Podoplanin is a negative regulator of Th17 inflammation.

Authors:  Alyssa N Nylander; Gerald D Ponath; Pierre-Paul Axisa; Mayyan Mubarak; Mary Tomayko; Vijay K Kuchroo; David Pitt; David A Hafler
Journal:  JCI Insight       Date:  2017-09-07

6.  The expression of podoplanin and classic cadherins in the mouse brain.

Authors:  Chiaki Kaji; Miwa Tomooka; Yukinari Kato; Hiroshi Kojima; Yoshihiko Sawa
Journal:  J Anat       Date:  2012-02-21       Impact factor: 2.610

7.  Genetic alterations of E-cadherin and beta-catenin in germinoma and teratoma: report of two central nervous system cases.

Authors:  Nives Pećina-Slaus; Tamara Niku Eva-Martić; Vili Beros; Davor Tomas
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

Review 8.  Podoplanin - a small glycoprotein with many faces.

Authors:  Maciej Ugorski; Piotr Dziegiel; Jaroslaw Suchanski
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

9.  The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.

Authors:  Akiko Kunita; Takeshi G Kashima; Yasuyuki Morishita; Masashi Fukayama; Yukinari Kato; Takashi Tsuruo; Naoya Fujita
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

10.  Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.

Authors:  Christiane Hammershaimb Mosbech; Terje Svingen; John Erik Nielsen; Birgitte Groenkaer Toft; Catherine Rechnitzer; Bodil Laub Petersen; Ewa Rajpert-De Meyts; Christina Engel Hoei-Hansen
Journal:  Virchows Arch       Date:  2014-07-30       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.